By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts.
China’s digital health transformation is driven by scale, centralisation, and state coordination. Western digital health, especially in Europe and the U.S., is shaped by private innovation, fragmented systems, and market incentives.
In 2025, these divergent models have led to two distinct futures:
Neither model is inherently better — but they shape different opportunities for companies.
China’s government-led approach allows:
When the entire population is within a coordinated system, nationwide innovation becomes exponentially easier.
China faces one of the world’s largest ageing populations, pushing aggressive investment in home monitoring, fall detection, and chronic disease management technologies.
COVID-19 accelerated development of population-scale digital tools and real-time surveillance.
Clinician shortages have pushed China toward automation-heavy care pathways.
Western healthtech ecosystems are defined by:
This leads to:
The downside is slower interoperability.
The upside is a thriving startup ecosystem.
China deploys AI at national scale — diagnostics, triage, and workflow automation are integrated into mainstream care.
In the West, AI adoption is:
Western AI tends to augment, not replace.
Chinese AI often reshapes workflows entirely.
Opportunities include:
However, companies must navigate:
Entering China requires localisation, not translation.
Key lessons:
China’s system shows what’s possible when digital infrastructure is prioritised.
Key lessons:
Western markets show the power of bottom-up creativity.
Global healthtech is heading toward a mixed model:
Understanding both strategies gives companies an edge — whether they’re expanding globally or designing products for culturally and structurally different markets.
We create human-centered solutions that drive positive outcomes for users and organisations. Let’s collaborate.
See our work
